Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC

NCT01290783 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Irintoecan
DRUG: HA-Irinotecan solution for Infusion

Sponsor

Alchemia Oncology